You Are Here: Home > About Arthritis > Arthritis in the News > Arthritis and Lupus patients running low on meds due to misinformation about COVID-19

Arthritis and Lupus patients running low on meds due to misinformation about COVID-19

Our Chief Science Officer, Dr. Sian Bevan, and arthritis ambassador Darlene McPherson, comment on how COVID-19 has led to a shortage of Hydroxychloroquine – a drug used to treat Rheumatoid Arthritis and Lupus – and how it's impacting patients. The Arthritis Society continues to advocate for preserving arthritis patients' access to needed medication.Back to News